Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: Sustained response in two patients with transfusion dependent thalassaemia

Medical Journal of Malaysia

Volumn 57, Issue 3, 2002, Pages 353-356

  Hamidah, A ^a   Yong, J F ^a   Zulkifli, H I ^a   Jamal, R ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Blood transfusion; Hepatitis C virus; Interferon; Ribavirin; Thalassaemia

Indexed keywords

ALPHA2B INTERFERON; FERRITIN; RIBAVIRIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; COMBINATION CHEMOTHERAPY; DRUG EFFICACY; FEMALE; FERRITIN BLOOD LEVEL; FLU LIKE SYNDROME; HEMOLYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; MALE; MONOTHERAPY; THALASSEMIA; TREATMENT FAILURE;

ADOLESCENT; ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; RIBAVIRIN; THALASSEMIA; TIME FACTORS;

EID: 0036761763     PISSN: 03005283     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Jamal R, Fadzillah G, Zulkifli SZ, Yasmin M. Seroprevalence of Hepatitis B, Hepatitis C, CMV and HIV in multiply transfused thalassemia patients: Results from a thalassemia day care center in Malaysia. Southeast Asian J Trop Public Health. December 1998; 29: 792-94.
2. Guidelines for the Clinical Management of Thalassaemia. Published by Thalassaemia International Federation. April 2000; 50-55.
3. Telfer PT, Garson JA, Whitby K et al. Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients. British Journal of Haematology. June 1997; 98: 850-55.